By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

Free Cancer Medicines For Children Prepared in Four Major Hospitals of Pakistan

Last updated: February 14, 2026 11:13 am
Neha Ashraf
Share
SHARE

An initiative of the World Health Organization and the Government of Pakistan, preparations for free cancer medicines for children have been completed in four major hospitals of Pakistan.

‎More than 8,000 Pakistani children are diagnosed with cancer every year, and by the end of 2026 the supply of free and quality cancer medicines will begin.

‎Pakistan has joined the global platform and become the second country in the region, with a target set to double the survival rate of children by 2030.

‎UNICEF will procure the medicines and ensure their delivery to Pakistan, while globally 400,000 children are diagnosed with cancer every year.

Share This Article
Email Copy Link Print
Previous Article Chief Minister Maryam Nawaz Expresses Gratitude Over Free Heart Surgeries of Thousands of Children
Next Article Primary Health Care is a National Priority, Vaccines Will Soon Be Produced Locally, Says Mustafa Kamal
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
At Least 20 Children Dead After School Roof Collapses in Pakistan
At Least 20 Children Dead After School Roof Collapses in Pakistan
Breaking Education pakistan
October 15, 2026
Darshan Raval's latest single 'Naal Naal Ve' explores love, longing, reality
Darshan Raval’s latest single ‘Naal Naal Ve’ explores love, longing, reality
Entertainment Headline
October 15, 2026
Ukraine’s Vulnerability Grows as Starlink Is Restricted and Russia Escalates
Ukraine’s Vulnerability Grows as Starlink Is Restricted and Russia Escalates
Headline Politics
October 15, 2026
World’s oldest known shipwreck found in Turkiye
World’s oldest known shipwreck found in Turkiye
Headline Maritime
October 15, 2026
Human extinction risks include malicious AI and nuclear famine in new Lancet data
Human extinction risks include malicious AI and nuclear famine in new Lancet data
Headline Technology
October 15, 2026
Petrol price rises, diesel rate falls in Pakistan
Petrol price rises, diesel rate falls in Pakistan
Economy Headline
October 15, 2026

You Might Also Like

WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
Health

Experts Share Surprising Health Benefits and Storage Tips for Olive Oil

By
Fatima Nadeem
CPSP Team Reviews SIUT’s Medical Training to Advance Postgraduate Education
Health

CPSP Team Reviews SIUT’s Medical Training to Advance Postgraduate Education

By
Misbah Jogyat
Why Mosquitoes Choose You: The Science Behind Being a Bite Magnet
Health

Why Mosquitoes Choose You: The Science Behind Being a Bite Magnet

By
Misbah Jogyat
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?